Nangaku M, Farag YMK, deGoma E, Luo W, et al. Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients. Nephrol Dial Transplant 2020 Jul 28. pii: 5877009. doi: 10.1093.
PMID: 32719868